NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

  title={NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.},
  author={Peter R. Carroll and J Kellogg Parsons and Gerald L. Andriole and Robert R. Bahnson and Erik Peter Castle and William J. Catalona and Douglas M. Dahl and John W Davis and Jonathan I. Epstein and Ruth B. Etzioni and Thomas A Farrington and George P. Hemstreet and Mark H. Kawachi and Simon P Kim and Paul H. Lange and Kevin Raymond Loughlin and William Thomas Lowrance and Paul D. Maroni and James L. Mohler and Todd M. Morgan and Kelvin A. Moses and Robert Brewster Nadler and Michael A. Poch and Chuck Scales and Terrence M. Shaneyfelt and Marc C Smaldone and Geoffrey Sonn and Preston C. Sprenkle and Andrew J. Vickers and Robert H. Wake and Dorothy A. Shead and Deborah A Freedman-Cass},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  volume={14 5},
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS